logo
logo
Sign in
Sara James 9h
img
The global Antibiotic Resistance Market size is expected to reach USD 12. The review further stated that there are only 27 new candidates under development, out of which only 6 are considered “innovative” enough to be capable of overcoming antibiotic resistance as defined by WHO. Related Press Release@ Antibiotic Resistance Market ReportAntibiotic Resistance Market Report HighlightsIn 2023, cUTI accounted for the largest market share and is anticipated to maintain its dominance in the global market in the coming yearsCombination drugs are expected to grow at the fastest CAGR over the forecast periodNorth America dominated the antibiotic resistance industry in 2023. 27% from 2024 to 2030Base year for estimation2023Historical data2018 - 2022Forecast period2024 - 2030 Request For A Free Consultation @ https://www. faeciumAntibiotic Resistance Drug Class Outlook (Revenue, USD Million, 2018 - 2030)OxazolidinonesLipoglycopeptidesTetracyclinesCombination therapiesCephalosporinsOthersAntibiotic Resistance Mechanism of Action Outlook (Revenue, USD Million, 2018 - 2030)Protein Synthesis InhibitorsCell Wall Synthesis InhibitorsRNA Synthesis InhibitorsDNA Synthesis InhibitorsOthersAntibiotic Resistance Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)Hospital PharmaciesRetail PharmaciesOnline PharmaciesAntibiotic Resistance Regional Outlook (Revenue, USD Million, 2018 - 2030)North AmericaU.
collect
0
Leena Shedmake 2024-03-22
img
The Global Antibiotic Resistance Market is estimated to be valued at US$ 8. The global antibiotic resistance market is driven by the rising prevalence of infectious diseases coupled with the increasing resistance of microbes to existing antibiotics. Key TakeawaysKey players operating in the Global Antibiotic Resistance Market Demand are Melinta Therapeutics, Merck & Co. Asia Pacific is anticipated to grow at the fastest pace in the antibiotic resistance market, majorly driven by China, India and other southeast Asian countries. Get more insights on Global Antibiotic Resistance Market  
collect
0
ashwinicmi 2024-03-06
, Tetraphase Pharmaceutical, Inc. , Tetraphase Pharmaceutical, Inc. PEST Analysis:A PEST analysis reveals the external factors shaping the Global Antibiotic Resistance Market Size. SWOT Analysis:Conducting a SWOT analysis offers insights into the internal dynamics of the Global Antibiotic Resistance Market. Challenges and Collaborations:While the Global Antibiotic Resistance Market strives for innovative solutions, it faces challenges such as the high cost and lengthy timelines associated with antibiotic development. Future Outlook:The future outlook for the Global Antibiotic Resistance Market hinges on collaborative efforts, technological advancements, and a global commitment to responsible antibiotic use.
collect
0
elliacytocaree 2022-07-18
img
They are perfect at manufacturing, packaging, and delivering antibiotic medicines to customers. In over 10+ countries across the world, their network of partners & customers is huge. In 2012 This company started with one vision of becoming a dedicated healthcare company in India for the improvement of human health. If you want the best antibiotic medicines then you must contact a healthcare company in Noida. com/antibiotics-manufacturer-in-india/Antibiotic Manufacturer in IndiaMedicine Manufacturer in IndiaBest Antibiotic Medicines
collect
0
atharva jadhav 2024-02-15
The Global Antibiotic Eye Drops Market Size was estimated at USD 740. The Europe market for Global Antibiotic Eye Drops market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030. This report provides a deep insight into the global Antibiotic Eye Drops market covering all its essential aspects. The report structure also focuses on the competitive landscape of the Global Antibiotic Eye Drops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. com/chapters-purchase/7892047/global-antibiotic-eye-drops-2024-808CONTACT US:276 5th Avenue, New York, NY 10001, United StatesInternational: +1(646)-781-7170 / +91 8087042414Similar Reports:2022-2027 Global and Regional Antibiotic Eye Drops Industry Status and Prospects Professional Market Research Report Standard Version2022-2027 Global and Regional Antibiotic Eye Drops Industry Status and Prospects Professional Market Research Report Standard VersionAntibiotic Eye Drops Market, Global Outlook and Forecast 2022-2028Antibiotic Eye Drops Market - Global Outlook and Forecast 2021-2027
collect
0
Persistence Market Research 2022-02-28
The Antibiotic Resistance Market is slated to grow unstoppably in the years to come. According to a latest report published by Persistence Market Research, the global antibiotic resistance market is projected to be valued at US$ 12. com/methodology/27895Key Takeaways from Antibiotic Resistance Market Study        Beta lactam antibiotics are expected to contribute more than 25% of the revenue share to the market by 2031. – +1-646-568-7751USA-Canada Toll-free – +1 800-961-0353Sales â€“ sales@persistencemarketresearch. comWebsite â€“ https://www.
collect
0
Saya Bonde 2023-12-05
img
The poultry antibiotic market is estimated to be valued at US$ 2. SWOT Analysis Strength: The poultry antibiotic market has stable demand due to essential nature of products in poultry farming. Key Takeaways The global poultry antibiotic market is expected to witness high growth, exhibiting CAGR of 6. The Asia Pacific region dominates the poultry antibiotic market currently, owing to large poultry meat producers like China and India. , Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co.
collect
0
naufan003 2024-03-22
img
Introduction to Bacteriophages Bacteriophages, also known as phages, are viruses that specifically infect and replicate within bacteria. The Potential of Bacteriophage Therapy The rise of antibiotic-resistant "superbugs" is a major public health concern. Meanwhile, bacteriophage therapy continues to be applied successfully in some parts of Eastern Europe and Georgia for treating various infections with few adverse effects reported. Continued development of phage therapy holds promise to strengthen our defenses against the growing threat of untreatable bacterial pathogens in the years ahead.  Get more insights on Bacteriophage Therapy
collect
0
kiran gire 2024-02-05
img
Need for fish vaccines Aquaculture plays a vital role in meeting the rising demand for food fish worldwide. However, diseases cost the global aquaculture industry millions each year. These diseases not only cause mass mortality in fish but also stall the growth of the aquaculture industry. This is where fish vaccines emerged as a game changer for the aquaculture sector. Some studies have reported benefit-cost ratios of over 50:1 for certain fish vaccines.
collect
0
shriya laturkar 2021-10-20
img

Antibiotic Resistance Market: Information by Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies and others), Disease (Complicated Urinary Tract Infection (cUTI), Blood Stream Infections (BDS), Complicated Intra-Abdominal Infections (cIAI), Clostridium Difficile Infections (CDI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community-Acquired Bacterial Pneumonia (CABP), Others), Pathogen (Staphylococcus Aureus , Streptococcus pneumonia, Acinetobacter, Enterococcus Faecium, Hemophilus Influenzae, Pseudomonas Aeruginosa, Clostridium Difficile, K. Pneumoniae, Others), End-User (Hospitals and Clinics, Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Antibiotic Resistance Market-OverviewThe popularity and effectiveness of antibiotics have risen exponentially since their mainstream introduction.

The pharmaceutical reports are made by Market Research Future, which includes market options for expansion.

A USD 13,146 Million is estimated to be accumulated by the market by 2025 while progressing at a CAGR of 5.8%.The natural occurrence of resistance to antibiotics to their intensive or prolonged use is estimated to create an augmented scope for the antibiotic resistance market growth.

Based on disease, the antibiotic resistance market has been segmented into hospital-acquired bacterial pneumonia/ventilator, complicated urinary tract infections, complicated intra-abdominal infections, bloodstream infections, community-acquired bacterial pneumonia, acute bacterial and skin structure infections, clostridium difficile infections, and others.

On the basis of pathogen, the antibiotic resistance market is segmented into streptococcus pneumoniae, k. pneumoniae, acinetobacter, staphylococcus aureus, enterococcus, pseudomonas aeruginosa, clostridium difficile, hemophilus influenzae, campylobacter, and others.Detailed Regional Analysis The regional examination of the antibiotic resistance market is conducted for regions such as Americas, Asia-Pacific the Middle East, Europe and Africa.

The intensifying growth in the pharmaceutical sector, intensifying approval of antibiotic resistance, mounting prevalence of communicable diseases are the noteworthy factors that would propel the development of the antibiotic resistance market in this region.

collect
0
MedicaPharma 2024-03-11
img
Introduction:When it comes to treating bacterial infections, having a reliable antibiotic on hand is essential for your health and well-being. In this blog, we'll explore why Doxycycline is your go-to antibiotic and how you can conveniently purchase it from MedicaPharma. The Power of Doxycycline:Doxycycline is a tetracycline antibiotic that is highly effective against a wide range of bacterial infections. Conclusion:Doxycycline is your go-to antibiotic for treating bacterial infections, and MedicaPharma is your trusted source for purchasing it online. Buy Doxycycline from MedicaPharma today and experience the difference that quality medication and exceptional service can make in your life.
collect
0
Vaibhav W 2022-06-14
img
According to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5. The growth of global antibiotic resistance market is driven by various factors such as -     Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistanceSeveral market players currently dominate the global antibiotic resistance market. Major Key Players:Some of the Key Players in the Global Antibiotic Resistance Market are Achaogen, Inc. The antibiotic resistance market in the Middle East & Africa has been divided into the Middle East and Africa. About Market Research FutureAt Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
collect
0
Ruchita Roy 2020-11-05
img

Market HighlightsAccording to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8,120 Million in 2018.Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs.

Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8579The growth of global antibiotic resistance market is driven by various factors such as - Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market.

The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others.

collect
0
shriya laturkar 2021-11-03
img

Antibiotic Resistance Market: Information by Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies and others), Disease (Complicated Urinary Tract Infection (cUTI), Blood Stream Infections (BDS), Complicated Intra-Abdominal Infections (cIAI), Clostridium Difficile Infections (CDI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community-Acquired Bacterial Pneumonia (CABP), Others), Pathogen (Staphylococcus Aureus , Streptococcus pneumonia, Acinetobacter, Enterococcus Faecium, Hemophilus Influenzae, Pseudomonas Aeruginosa, Clostridium Difficile, K. Pneumoniae, Others), End-User (Hospitals and Clinics, Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Antibiotic Resistance Market-OverviewThe popularity and effectiveness of antibiotics have risen exponentially since their mainstream introduction.

The pharmaceutical reports are made by Market Research Future, which includes market options for expansion.

A USD 13,146 Million is estimated to be accumulated by the market by 2025 while progressing at a CAGR of 5.8%.The natural occurrence of resistance to antibiotics to their intensive or prolonged use is estimated to create an augmented scope for the antibiotic resistance market growth.

Based on disease, the antibiotic resistance market has been segmented into hospital-acquired bacterial pneumonia/ventilator, complicated urinary tract infections, complicated intra-abdominal infections, bloodstream infections, community-acquired bacterial pneumonia, acute bacterial and skin structure infections, clostridium difficile infections, and others.

On the basis of pathogen, the antibiotic resistance market is segmented into streptococcus pneumoniae, k. pneumoniae, acinetobacter, staphylococcus aureus, enterococcus, pseudomonas aeruginosa, clostridium difficile, hemophilus influenzae, campylobacter, and others.Detailed Regional Analysis The regional examination of the antibiotic resistance market is conducted for regions such as Americas, Asia-Pacific the Middle East, Europe and Africa.

The intensifying growth in the pharmaceutical sector, intensifying approval of antibiotic resistance, mounting prevalence of communicable diseases are the noteworthy factors that would propel the development of the antibiotic resistance market in this region.

collect
0
Reshu Gupta 2021-03-05

Antibiotic Resistance Market Analysis  The antibiotic resistance market is likely touch USD 13,146 million at a 5.8% CAGR between 2019- 2025, as per the new Market Research Future’s antibiotic resistance statistics.

Others have again been segmented into vancomycin, sulfonamide, and others.

Of these, combination therapies will lead the market over the forecast period for the rising use of such therapies for gram-negative infections, which have limited treatment.

By disease, the antibiotic resistance market is segmented into community-acquired bacterial pneumonia, hospital-acquired bacterial pneumonia/ventilator, acute bacterial skim & skin structure infections, clostridium difficile infections, complicated intra-abdominal infections, bloodstream infections, and complicated urinary tract infection.

By pathogen, the antibiotic resistance market is segmented into campylobacter, pneumonia, clostridium difficile, pseudomonas aeruginosa, hemophilus influenza, enterococcus, acinetobacter, streptococcus pneumonia, staphylococcus aureus, and others.

Antibiotic Resistance Market Regional Analysis  By region, the global antibiotic resistance market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA).

collect
0
Reshu Gupta 2021-02-22

 Market HighlightsAccording to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8,120 Million in 2018.Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs.

Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistanceSeveral market players currently dominate the global antibiotic resistance market.

The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others.

collect
0
Sara James 9h
img
The global Antibiotic Resistance Market size is expected to reach USD 12. The review further stated that there are only 27 new candidates under development, out of which only 6 are considered “innovative” enough to be capable of overcoming antibiotic resistance as defined by WHO. Related Press Release@ Antibiotic Resistance Market ReportAntibiotic Resistance Market Report HighlightsIn 2023, cUTI accounted for the largest market share and is anticipated to maintain its dominance in the global market in the coming yearsCombination drugs are expected to grow at the fastest CAGR over the forecast periodNorth America dominated the antibiotic resistance industry in 2023. 27% from 2024 to 2030Base year for estimation2023Historical data2018 - 2022Forecast period2024 - 2030 Request For A Free Consultation @ https://www. faeciumAntibiotic Resistance Drug Class Outlook (Revenue, USD Million, 2018 - 2030)OxazolidinonesLipoglycopeptidesTetracyclinesCombination therapiesCephalosporinsOthersAntibiotic Resistance Mechanism of Action Outlook (Revenue, USD Million, 2018 - 2030)Protein Synthesis InhibitorsCell Wall Synthesis InhibitorsRNA Synthesis InhibitorsDNA Synthesis InhibitorsOthersAntibiotic Resistance Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)Hospital PharmaciesRetail PharmaciesOnline PharmaciesAntibiotic Resistance Regional Outlook (Revenue, USD Million, 2018 - 2030)North AmericaU.
ashwinicmi 2024-03-06
, Tetraphase Pharmaceutical, Inc. , Tetraphase Pharmaceutical, Inc. PEST Analysis:A PEST analysis reveals the external factors shaping the Global Antibiotic Resistance Market Size. SWOT Analysis:Conducting a SWOT analysis offers insights into the internal dynamics of the Global Antibiotic Resistance Market. Challenges and Collaborations:While the Global Antibiotic Resistance Market strives for innovative solutions, it faces challenges such as the high cost and lengthy timelines associated with antibiotic development. Future Outlook:The future outlook for the Global Antibiotic Resistance Market hinges on collaborative efforts, technological advancements, and a global commitment to responsible antibiotic use.
atharva jadhav 2024-02-15
The Global Antibiotic Eye Drops Market Size was estimated at USD 740. The Europe market for Global Antibiotic Eye Drops market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030. This report provides a deep insight into the global Antibiotic Eye Drops market covering all its essential aspects. The report structure also focuses on the competitive landscape of the Global Antibiotic Eye Drops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. com/chapters-purchase/7892047/global-antibiotic-eye-drops-2024-808CONTACT US:276 5th Avenue, New York, NY 10001, United StatesInternational: +1(646)-781-7170 / +91 8087042414Similar Reports:2022-2027 Global and Regional Antibiotic Eye Drops Industry Status and Prospects Professional Market Research Report Standard Version2022-2027 Global and Regional Antibiotic Eye Drops Industry Status and Prospects Professional Market Research Report Standard VersionAntibiotic Eye Drops Market, Global Outlook and Forecast 2022-2028Antibiotic Eye Drops Market - Global Outlook and Forecast 2021-2027
Saya Bonde 2023-12-05
img
The poultry antibiotic market is estimated to be valued at US$ 2. SWOT Analysis Strength: The poultry antibiotic market has stable demand due to essential nature of products in poultry farming. Key Takeaways The global poultry antibiotic market is expected to witness high growth, exhibiting CAGR of 6. The Asia Pacific region dominates the poultry antibiotic market currently, owing to large poultry meat producers like China and India. , Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co.
kiran gire 2024-02-05
img
Need for fish vaccines Aquaculture plays a vital role in meeting the rising demand for food fish worldwide. However, diseases cost the global aquaculture industry millions each year. These diseases not only cause mass mortality in fish but also stall the growth of the aquaculture industry. This is where fish vaccines emerged as a game changer for the aquaculture sector. Some studies have reported benefit-cost ratios of over 50:1 for certain fish vaccines.
MedicaPharma 2024-03-11
img
Introduction:When it comes to treating bacterial infections, having a reliable antibiotic on hand is essential for your health and well-being. In this blog, we'll explore why Doxycycline is your go-to antibiotic and how you can conveniently purchase it from MedicaPharma. The Power of Doxycycline:Doxycycline is a tetracycline antibiotic that is highly effective against a wide range of bacterial infections. Conclusion:Doxycycline is your go-to antibiotic for treating bacterial infections, and MedicaPharma is your trusted source for purchasing it online. Buy Doxycycline from MedicaPharma today and experience the difference that quality medication and exceptional service can make in your life.
Ruchita Roy 2020-11-05
img

Market HighlightsAccording to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8,120 Million in 2018.Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs.

Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8579The growth of global antibiotic resistance market is driven by various factors such as - Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market.

The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others.

Reshu Gupta 2021-03-05

Antibiotic Resistance Market Analysis  The antibiotic resistance market is likely touch USD 13,146 million at a 5.8% CAGR between 2019- 2025, as per the new Market Research Future’s antibiotic resistance statistics.

Others have again been segmented into vancomycin, sulfonamide, and others.

Of these, combination therapies will lead the market over the forecast period for the rising use of such therapies for gram-negative infections, which have limited treatment.

By disease, the antibiotic resistance market is segmented into community-acquired bacterial pneumonia, hospital-acquired bacterial pneumonia/ventilator, acute bacterial skim & skin structure infections, clostridium difficile infections, complicated intra-abdominal infections, bloodstream infections, and complicated urinary tract infection.

By pathogen, the antibiotic resistance market is segmented into campylobacter, pneumonia, clostridium difficile, pseudomonas aeruginosa, hemophilus influenza, enterococcus, acinetobacter, streptococcus pneumonia, staphylococcus aureus, and others.

Antibiotic Resistance Market Regional Analysis  By region, the global antibiotic resistance market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA).

Leena Shedmake 2024-03-22
img
The Global Antibiotic Resistance Market is estimated to be valued at US$ 8. The global antibiotic resistance market is driven by the rising prevalence of infectious diseases coupled with the increasing resistance of microbes to existing antibiotics. Key TakeawaysKey players operating in the Global Antibiotic Resistance Market Demand are Melinta Therapeutics, Merck & Co. Asia Pacific is anticipated to grow at the fastest pace in the antibiotic resistance market, majorly driven by China, India and other southeast Asian countries. Get more insights on Global Antibiotic Resistance Market  
elliacytocaree 2022-07-18
img
They are perfect at manufacturing, packaging, and delivering antibiotic medicines to customers. In over 10+ countries across the world, their network of partners & customers is huge. In 2012 This company started with one vision of becoming a dedicated healthcare company in India for the improvement of human health. If you want the best antibiotic medicines then you must contact a healthcare company in Noida. com/antibiotics-manufacturer-in-india/Antibiotic Manufacturer in IndiaMedicine Manufacturer in IndiaBest Antibiotic Medicines
Persistence Market Research 2022-02-28
The Antibiotic Resistance Market is slated to grow unstoppably in the years to come. According to a latest report published by Persistence Market Research, the global antibiotic resistance market is projected to be valued at US$ 12. com/methodology/27895Key Takeaways from Antibiotic Resistance Market Study        Beta lactam antibiotics are expected to contribute more than 25% of the revenue share to the market by 2031. – +1-646-568-7751USA-Canada Toll-free – +1 800-961-0353Sales â€“ sales@persistencemarketresearch. comWebsite â€“ https://www.
naufan003 2024-03-22
img
Introduction to Bacteriophages Bacteriophages, also known as phages, are viruses that specifically infect and replicate within bacteria. The Potential of Bacteriophage Therapy The rise of antibiotic-resistant "superbugs" is a major public health concern. Meanwhile, bacteriophage therapy continues to be applied successfully in some parts of Eastern Europe and Georgia for treating various infections with few adverse effects reported. Continued development of phage therapy holds promise to strengthen our defenses against the growing threat of untreatable bacterial pathogens in the years ahead.  Get more insights on Bacteriophage Therapy
shriya laturkar 2021-10-20
img

Antibiotic Resistance Market: Information by Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies and others), Disease (Complicated Urinary Tract Infection (cUTI), Blood Stream Infections (BDS), Complicated Intra-Abdominal Infections (cIAI), Clostridium Difficile Infections (CDI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community-Acquired Bacterial Pneumonia (CABP), Others), Pathogen (Staphylococcus Aureus , Streptococcus pneumonia, Acinetobacter, Enterococcus Faecium, Hemophilus Influenzae, Pseudomonas Aeruginosa, Clostridium Difficile, K. Pneumoniae, Others), End-User (Hospitals and Clinics, Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Antibiotic Resistance Market-OverviewThe popularity and effectiveness of antibiotics have risen exponentially since their mainstream introduction.

The pharmaceutical reports are made by Market Research Future, which includes market options for expansion.

A USD 13,146 Million is estimated to be accumulated by the market by 2025 while progressing at a CAGR of 5.8%.The natural occurrence of resistance to antibiotics to their intensive or prolonged use is estimated to create an augmented scope for the antibiotic resistance market growth.

Based on disease, the antibiotic resistance market has been segmented into hospital-acquired bacterial pneumonia/ventilator, complicated urinary tract infections, complicated intra-abdominal infections, bloodstream infections, community-acquired bacterial pneumonia, acute bacterial and skin structure infections, clostridium difficile infections, and others.

On the basis of pathogen, the antibiotic resistance market is segmented into streptococcus pneumoniae, k. pneumoniae, acinetobacter, staphylococcus aureus, enterococcus, pseudomonas aeruginosa, clostridium difficile, hemophilus influenzae, campylobacter, and others.Detailed Regional Analysis The regional examination of the antibiotic resistance market is conducted for regions such as Americas, Asia-Pacific the Middle East, Europe and Africa.

The intensifying growth in the pharmaceutical sector, intensifying approval of antibiotic resistance, mounting prevalence of communicable diseases are the noteworthy factors that would propel the development of the antibiotic resistance market in this region.

Vaibhav W 2022-06-14
img
According to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5. The growth of global antibiotic resistance market is driven by various factors such as -     Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistanceSeveral market players currently dominate the global antibiotic resistance market. Major Key Players:Some of the Key Players in the Global Antibiotic Resistance Market are Achaogen, Inc. The antibiotic resistance market in the Middle East & Africa has been divided into the Middle East and Africa. About Market Research FutureAt Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
shriya laturkar 2021-11-03
img

Antibiotic Resistance Market: Information by Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies and others), Disease (Complicated Urinary Tract Infection (cUTI), Blood Stream Infections (BDS), Complicated Intra-Abdominal Infections (cIAI), Clostridium Difficile Infections (CDI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community-Acquired Bacterial Pneumonia (CABP), Others), Pathogen (Staphylococcus Aureus , Streptococcus pneumonia, Acinetobacter, Enterococcus Faecium, Hemophilus Influenzae, Pseudomonas Aeruginosa, Clostridium Difficile, K. Pneumoniae, Others), End-User (Hospitals and Clinics, Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Antibiotic Resistance Market-OverviewThe popularity and effectiveness of antibiotics have risen exponentially since their mainstream introduction.

The pharmaceutical reports are made by Market Research Future, which includes market options for expansion.

A USD 13,146 Million is estimated to be accumulated by the market by 2025 while progressing at a CAGR of 5.8%.The natural occurrence of resistance to antibiotics to their intensive or prolonged use is estimated to create an augmented scope for the antibiotic resistance market growth.

Based on disease, the antibiotic resistance market has been segmented into hospital-acquired bacterial pneumonia/ventilator, complicated urinary tract infections, complicated intra-abdominal infections, bloodstream infections, community-acquired bacterial pneumonia, acute bacterial and skin structure infections, clostridium difficile infections, and others.

On the basis of pathogen, the antibiotic resistance market is segmented into streptococcus pneumoniae, k. pneumoniae, acinetobacter, staphylococcus aureus, enterococcus, pseudomonas aeruginosa, clostridium difficile, hemophilus influenzae, campylobacter, and others.Detailed Regional Analysis The regional examination of the antibiotic resistance market is conducted for regions such as Americas, Asia-Pacific the Middle East, Europe and Africa.

The intensifying growth in the pharmaceutical sector, intensifying approval of antibiotic resistance, mounting prevalence of communicable diseases are the noteworthy factors that would propel the development of the antibiotic resistance market in this region.

Reshu Gupta 2021-02-22

 Market HighlightsAccording to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8,120 Million in 2018.Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs.

Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistanceSeveral market players currently dominate the global antibiotic resistance market.

The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others.

1 of 62